Welcome Guest | Register / Login

Cancer Market Research Reports

Sort By
Title Published Price
Thyroid Cancer - Pipeline Insight, 2020
By Delve Insight
Thyroid Cancer Overview "Thyroid Cancer Pipeline Insight, 2020" Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical Development Scenario And Growth Prospects Across The Thyroid Cancer Market. A Detailed Picture Of...
Jan 2020 $ 1250
Thymus Cancer - Pipeline Insight, 2020
By Delve Insight
Thymus Cancer Overview "Thymus Cancer Pipeline Insight, 2020" Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical Development Scenario And Growth Prospects Across The Thymus Cancer Market. A Detailed Picture Of Th...
Jan 2020 $ 1250
Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Insight, 2020
By Delve Insight
Recurrent Head And Neck Cancer Squamous Cell Carcinoma Overview "Recurrent Head And Neck Cancer Squamous Cell Carcinoma Pipeline Insight, 2020" Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical Development Scena...
Jan 2020 $ 1250
Small Cell Lung Cancer - Pipeline Insight, 2020
By Delve Insight
Small Cell Lung Cancer Overview "Small Cell Lung Cancer Pipeline Insight, 2020" Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical Development Scenario And Growth Prospects Across The Small Cell Lung Cancer Marke...
Jan 2020 $ 1250
Papillary Thyroid Cancer - Pipeline Insight, 2020
By Delve Insight
Papillary Thyroid Cancer Overview "Papillary Thyroid Cancer Pipeline Insight, 2020" Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical Development Scenario And Growth Prospects Across The Papillary Thyroid Cancer...
Jan 2020 $ 1250
Vulvar Cancer - Pipeline Insight, 2020
By Delve Insight
Vulvar Cancer Overview "Vulvar Cancer Pipeline Insight, 2020" Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical Development Scenario And Growth Prospects Across The Vulvar Cancer Market. A Detailed Picture Of Th...
Jan 2020 $ 1250
Metastatic Liver Cancer - Pipeline Insight, 2020
By Delve Insight
Metastatic Liver Cancer Overview "Metastatic Liver Cancer Pipeline Insight, 2020" Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical Development Scenario And Growth Prospects Across The Metastatic Liver Cancer Ma...
Jan 2020 $ 1250
Medullary Thyroid Cancer - Pipeline Insight, 2020
By Delve Insight
Medullary Thyroid Cancer Overview "Medullary Thyroid Cancer Pipeline Insight, 2020" Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical Development Scenario And Growth Prospects Across The Medullary Thyroid Cancer...
Jan 2020 $ 1250
Nasopharyngeal Cancer - Pipeline Insight, 2020
By Delve Insight
Nasopharyngeal Cancer Overview "Nasopharyngeal Cancer Pipeline Insight, 2020" Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical Development Scenario And Growth Prospects Across The Nasopharyngeal Cancer Market. ...
Jan 2020 $ 1250
Non Muscle Invasive Bladder Cancer - Pipeline Insight, 2020
By Delve Insight
Non Muscle Invasive Bladder Cancer Overview "Non Muscle Invasive Bladder Cancer Pipeline Insight, 2020" Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical Development Scenario And Growth Prospects Across The Non ...
Jan 2020 $ 1250
Gallbladder Cancer - Pipeline Insight, 2020
By Delve Insight
Gallbladder Cancer Overview "Gallbladder Cancer Pipeline Insight, 2020" Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical Development Scenario And Growth Prospects Across The Gallbladder Cancer Market. A Detaile...
Jan 2020 $ 1250
Cancer Cachexia - Pipeline Insight, 2020
By Delve Insight
Cancer Cachexia Overview "Cancer Cachexia Pipeline Insight, 2020" Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical Development Scenario And Growth Prospects Across The Cancer Cachexia Market. A Detailed Picture...
Jan 2020 $ 1250
Anaplastic Thyroid Cancer - Pipeline Insight, 2020
By Delve Insight
Anaplastic Thyroid Cancer Overview "Anaplastic Thyroid Cancer Pipeline Insight, 2020" Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical Development Scenario And Growth Prospects Across The Anaplastic Thyroid Can...
Jan 2020 $ 1250
Metastatic Prostate Cancer - Pipeline Insight, 2020
By Delve Insight
Metastatic Prostate Cancer Overview "Metastatic Prostate Cancer Pipeline Insight, 2020" Report By DelveInsight Outlays Comprehensive Insights Of Present Clinical Development Scenario And Growth Prospects Across The Metastatic Prostate ...
Jan 2020 $ 1250
MEDITE Cancer Diagnostics Inc (MDIT) - Financial and Strategic SWOT Analysis Review
By GlobalData
MEDITE Cancer Diagnostics Inc (MDIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and a...
Jan 2020 $ 125
Cancer Diagnostic Instrumentation: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers
By Venture Planning Group
This report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing. Contains 25 pages...
Dec 2019 $ 1450
University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review
By GlobalData
University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, informati...
Oct 2019 $ 125
Cancer Diagnostic Instrumentation 2019: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers
By Venture Planning Group
This report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing. Contains 25 pages...
Jul 2019 $ 1450
Global Oncology/Cancer Blockbuster Drugs Market Research Report 2019 - 2025
By DPI Research
The global 27 cancer blockbuster drugs market size is set to surpass US$ 120 billion by 2025. “Global Oncology/Cancer Blockbuster Drugs Market Research Report 2019 - 2025” presents an in-depth ...
Apr 2019 $ 1390
Cancer Genetics Inc (CGIX) - Financial and Strategic SWOT Analysis Review
By GlobalData
Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that provides diagnostics products and services in oncology areas. The company offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. Its onc...
Mar 2019 $ 300
2019-2023 Cancer Diagnostic Instrumentation: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers
By Venture Planning Group
This report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing. Contains 25 pages...
Jan 2019 $ 950
North America Cancer Biomarker Market Forecast 2019-2027
By Inkwood Research
KEY FINDINGS The North American cancer biomarker market is all set to expand with a CAGR of 10.41% between the forecasted years of 2019-2027. The region holds the highest share in the global cancer biomarker market and also contribute the maxi...
Jan 2019 $ 1250
Europe Cancer Biomarker Market Forecast 2019-2027
By Inkwood Research
KEY FINDINGS The Europe cancer biomarker market is poised to grow at a CAGR of 10.83% for the years 2019-2027. Technological progress in research and developmental activities has progressed the growth of the cancer biomarker market in Europe....
Jan 2019 $ 1250
Asia Pacific Cancer Biomarker Market Forecast 2019-2027
By Inkwood Research
KEY FINDINGS The Asia-Pacific cancer biomarkers market is expected to rise with a CAGR of 13.23% for the years 2019-2027. Development in the healthcare facility in the region and growing government efforts to increase awareness are the major d...
Jan 2019 $ 1250
OHSU Knight Cancer Institute - Medical Equipment - Deals and Alliances Profile
By GlobalData
Summary OHSU Knight Cancer Institute (OHSU Knight), a subsidiary of Oregon Health & Science University is a provider of various therapies for cancer treatments. The institute conducts clinical trials to develop therapies for cancer treat...
Dec 2018 $ 250
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy